Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 265 to 268 of 268 entries
Sorted by: Best Match Show Resources per page
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

Nature medicine

Nassif ME, Windsor SL, Borlaug BA, Kitzman DW, Shah SJ, Tang F, Khariton Y, Malik AO, Khumri T, Umpierrez G, Lamba S, Sharma K, Khan SS, Chandra L, Gordon RA, Ryan JJ, Chaudhry SP, Joseph SM, Chow CH, Kanwar MK, Pursley M, Siraj ES, Lewis GD, Clemson BS, Fong M, Kosiborod MN.
PMID: 34711976
Nat Med. 2021 Nov;27(11):1954-1960. doi: 10.1038/s41591-021-01536-x. Epub 2021 Oct 28.

Patients with heart failure and preserved ejection fraction (HFpEF) have a high burden of symptoms and functional limitations, and have a poor quality of life. By targeting cardiometabolic abmormalities, sodium glucose cotransporter 2 (SGLT2) inhibitors may improve these impairments....

Cite
Nassif ME, Windsor SL, Borlaug BA, et al. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat Med. 2021;27(11):1954-1960doi: 10.1038/s41591-021-01536-x.
Nassif, M. E., Windsor, S. L., Borlaug, B. A., Kitzman, D. W., Shah, S. J., Tang, F., Khariton, Y., Malik, A. O., Khumri, T., Umpierrez, G., Lamba, S., Sharma, K., Khan, S. S., Chandra, L., Gordon, R. A., Ryan, J. J., Chaudhry, S. P., Joseph, S. M., Chow, C. H., Kanwar, M. K., Pursley, M., Siraj, E. S., Lewis, G. D., Clemson, B. S., Fong, M., & Kosiborod, M. N. (2021). The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nature medicine, 27(11), 1954-1960. https://doi.org/10.1038/s41591-021-01536-x
Nassif, Michael E, et al. "The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial." Nature medicine vol. 27,11 (2021): 1954-1960. doi: https://doi.org/10.1038/s41591-021-01536-x
Nassif ME, Windsor SL, Borlaug BA, Kitzman DW, Shah SJ, Tang F, Khariton Y, Malik AO, Khumri T, Umpierrez G, Lamba S, Sharma K, Khan SS, Chandra L, Gordon RA, Ryan JJ, Chaudhry SP, Joseph SM, Chow CH, Kanwar MK, Pursley M, Siraj ES, Lewis GD, Clemson BS, Fong M, Kosiborod MN. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat Med. 2021 Nov;27(11):1954-1960. doi: 10.1038/s41591-021-01536-x. Epub 2021 Oct 28. PMID: 34711976; PMCID: PMC8604725.
Copy Download .nbib Format: NLM
Psychologists update their beliefs about effect sizes after replication studies.

Nature human behaviour

McDiarmid AD, Tullett AM, Whitt CM, Vazire S, Smaldino PE, Stephens JE.
PMID: 34811490
Nat Hum Behav. 2021 Dec;5(12):1663-1673. doi: 10.1038/s41562-021-01220-7. Epub 2021 Nov 22.

Self-correction-a key feature distinguishing science from pseudoscience-requires that scientists update their beliefs in light of new evidence. However, people are often reluctant to change their beliefs. We examined belief updating in action by tracking research psychologists' beliefs in psychological...

Cite
McDiarmid AD, Tullett AM, Whitt CM, et al. Psychologists update their beliefs about effect sizes after replication studies. Nat Hum Behav. 2021;5(12):1663-1673doi: 10.1038/s41562-021-01220-7.
McDiarmid, A. D., Tullett, A. M., Whitt, C. M., Vazire, S., Smaldino, P. E., & Stephens, J. E. (2021). Psychologists update their beliefs about effect sizes after replication studies. Nature human behaviour, 5(12), 1663-1673. https://doi.org/10.1038/s41562-021-01220-7
McDiarmid, Alex D, et al. "Psychologists update their beliefs about effect sizes after replication studies." Nature human behaviour vol. 5,12 (2021): 1663-1673. doi: https://doi.org/10.1038/s41562-021-01220-7
McDiarmid AD, Tullett AM, Whitt CM, Vazire S, Smaldino PE, Stephens JE. Psychologists update their beliefs about effect sizes after replication studies. Nat Hum Behav. 2021 Dec;5(12):1663-1673. doi: 10.1038/s41562-021-01220-7. Epub 2021 Nov 22. PMID: 34811490.
Copy Download .nbib Format: NLM
On-the-Fly Phase Transition and Density Changes of Aqueous Two-Phase Systems on a Centrifugal Microfluidic Platform.

Langmuir : the ACS journal of surfaces and colloids

Moon BU, Clime L, Hernandez-Castro JA, Brassard D, Nassif C, Malic L, Veres T.
PMID: 34928624
Langmuir. 2022 Jan 11;38(1):79-85. doi: 10.1021/acs.langmuir.1c01923. Epub 2021 Dec 20.

This paper describes on-the-fly physical property changes of aqueous two-phase systems (ATPS) in microfluidic devices. The properties and phases of the ATPS are modulated on-demand by using a centrifugal microfluidic device filled with poly(ethylene glycol) (PEG) and dextran (DEX)...

Cite
Moon BU, Clime L, Hernandez-Castro JA, et al. On-the-Fly Phase Transition and Density Changes of Aqueous Two-Phase Systems on a Centrifugal Microfluidic Platform. Langmuir. 2021;38(1):79-85doi: 10.1021/acs.langmuir.1c01923.
Moon, B. U., Clime, L., Hernandez-Castro, J. A., Brassard, D., Nassif, C., Malic, L., & Veres, T. (2022). On-the-Fly Phase Transition and Density Changes of Aqueous Two-Phase Systems on a Centrifugal Microfluidic Platform. Langmuir : the ACS journal of surfaces and colloids, 38(1), 79-85. https://doi.org/10.1021/acs.langmuir.1c01923
Moon, Byeong-Ui, et al. "On-the-Fly Phase Transition and Density Changes of Aqueous Two-Phase Systems on a Centrifugal Microfluidic Platform." Langmuir : the ACS journal of surfaces and colloids vol. 38,1 (2022): 79-85. doi: https://doi.org/10.1021/acs.langmuir.1c01923
Moon BU, Clime L, Hernandez-Castro JA, Brassard D, Nassif C, Malic L, Veres T. On-the-Fly Phase Transition and Density Changes of Aqueous Two-Phase Systems on a Centrifugal Microfluidic Platform. Langmuir. 2022 Jan 11;38(1):79-85. doi: 10.1021/acs.langmuir.1c01923. Epub 2021 Dec 20. PMID: 34928624.
Copy Download .nbib Format: NLM
A cross-sectional study of auditory verbal hallucinations experienced by people with a diagnosis of borderline personality disorder.

Clinical psychology & psychotherapy

Hayward M, Jones AM, Strawson WH, Quadt L, Larsson DEO, Silva M, Davies G, Fielding-Smith S, Hazell CM, Critchley HD, Garfinkel SN.
PMID: 34322956
Clin Psychol Psychother. 2021 Jul 28; doi: 10.1002/cpp.2655. Epub 2021 Jul 28.

BACKGROUND: The presence of auditory verbal hallucinations (AVHs) does not currently feature in the main diagnostic criteria for borderline personality disorder (BPD). However, there is accumulating evidence that a high proportion of BPD patients report longstanding and frequent AVHs...

Cite
Hayward M, Jones AM, Strawson WH, et al. A cross-sectional study of auditory verbal hallucinations experienced by people with a diagnosis of borderline personality disorder. Clin Psychol Psychother. 2021;doi: 10.1002/cpp.2655.
Hayward, M., Jones, A. M., Strawson, W. H., Quadt, L., Larsson, D. E. O., Silva, M., Davies, G., Fielding-Smith, S., Hazell, C. M., Critchley, H. D., & Garfinkel, S. N. (2021). A cross-sectional study of auditory verbal hallucinations experienced by people with a diagnosis of borderline personality disorder. Clinical psychology & psychotherapy, . https://doi.org/10.1002/cpp.2655
Hayward, Mark, et al. "A cross-sectional study of auditory verbal hallucinations experienced by people with a diagnosis of borderline personality disorder." Clinical psychology & psychotherapy vol. (2021). doi: https://doi.org/10.1002/cpp.2655
Hayward M, Jones AM, Strawson WH, Quadt L, Larsson DEO, Silva M, Davies G, Fielding-Smith S, Hazell CM, Critchley HD, Garfinkel SN. A cross-sectional study of auditory verbal hallucinations experienced by people with a diagnosis of borderline personality disorder. Clin Psychol Psychother. 2021 Jul 28; doi: 10.1002/cpp.2655. Epub 2021 Jul 28. PMID: 34322956.
Copy Download .nbib Format: NLM
Showing 265 to 268 of 268 entries